Cargando…

Effect of electronic prescribing with formulary decision support on medication tier, copayments, and adherence

BACKGROUND: Medication non-adherence is prevalent. We assessed the effect of electronic prescribing (e-prescribing) with formulary decision support on preferred formulary tier usage, copayment, and concomitant adherence. METHODS: We retrospectively analyzed 14,682 initial pharmaceutical claims for a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pevnick, Joshua M, Li, Ning, Asch, Steven M, Jackevicius, Cynthia A, Bell, Douglas S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4236533/ https://www.ncbi.nlm.nih.gov/pubmed/25167807 http://dx.doi.org/10.1186/1472-6947-14-79

Ejemplares similares

Moving Branded Statins to Lowest Copay Tier Improves Patient Adherence
por: Chen, Shih-Yin, et al.
Publicado: (2014)

Unraveling the Effects of Tier-Copayment Drug Benefit Designs
por: Curtiss, Frederic R.
Publicado: (2003)

Assessing the Association of Formulary Copayment Changes with Real-World Treatment Patterns in Patients with Rheumatoid Arthritis on Etanercept
por: Bonafede, Machaon, et al.
Publicado: (2020)

Associations Between Copays, Coverage Limits for Naloxone, and Prescribing in Medicaid
por: Messinger, John C, et al.
Publicado: (2022)

Effect of Patient Notification of Formulary Change on Formulary Adherence
por: Delate, Thomas, et al.
Publicado: (2005)

Hypertension, Prescription Drug Copayments, and Drug Therapy Adherence
por: Curtiss, Frederic R.
Publicado: (2003)

Comparison of tiered formularies and reference pricing policies: a systematic review
por: Morgan, Steve, et al.
Publicado: (2009)

Prescription Writing and Formulary. The Art of Prescribing
Publicado: (1936)

Association Between Copayment and Adherence to Medications for Pulmonary Arterial Hypertension
por: Schikowski, Erin M., et al.
Publicado: (2022)

Association of patient copayment and medication adherence in systemic lupus erythematosus
por: Lomanto Silva, Raisa, et al.
Publicado: (2023)

The effects of introducing an electronic prescription system with no copayments
por: Eriksen, Ida Iren, et al.
Publicado: (2015)

Alternate Financial Incentives in Multi-tiered Formulary Systems to Improve Accountability for Outcomes
por: Chung, Richard S., et al.
Publicado: (2003)

Pharmacoeconomic Modeling of Prior-Authorization Intervention for COX-2 Specific Inhibitors in a 3-Tier Copay Plan
por: Stacy, Jan, et al.
Publicado: (2003)

The Effect of Zero Copayments on Medication Adherence in a Community Pharmacy Setting
por: Jimenez, Melissa, et al.
Publicado: (2019)

3-Tier Drug Benefit Designs Based on Sound Drug Formulary Principles Will Maximize Favorable Outcomes
por: Curtiss, Frederic R.
Publicado: (2004)

Critical Review of Prasugrel for Formulary Decision Makers
por: Schafer, Jeremy
Publicado: (2009)

Cost-Effectiveness Analysis and the Formulary Decision-Making Process
por: Wang, Zhixiao, et al.
Publicado: (2004)

Family Physician attitudes about prescribing using a drug formulary
por: Suggs, L Suzanne, et al.
Publicado: (2009)

Emollient prescribing formularies in England and Wales: a cross-sectional study
por: Chan, Jonathan P, et al.
Publicado: (2018)

Formulary tiers, medication cost sharing, and transparency in bronze and silver qualified health plans in 2014 vs 2018
por: Hung, Anna, et al.
Publicado: (2021)

Association of Copayment with Likelihood and Level of Adherence in New Users of Statins: A Retrospective Cohort Study
por: Watanabe, Jonathan H., et al.
Publicado: (2014)

A Prescription for Improving Drug Formulary Decision Making
por: Schiff, Gordon D., et al.
Publicado: (2012)

Pharmacopoeias and formularies
por: Earles, M P
Publicado: (1999)

Influence of Hospital Formularies on Outpatient Prescribing Practices: Analysis of the Introduction of a Local Formulary: A Single-Center, 2-Year Follow-Up, Retrospective Cohort Study of a Local Formulary in Japan
por: Kanai, Norihito, et al.
Publicado: (2022)

Patient perceptions of copay card utilization and policies
por: Cavalier, Dimika, et al.
Publicado: (2023)

Emollient prescribing formularies and guidelines in England, 2021: a cross‐sectional study
por: Amakye, Nana Yaa T., et al.
Publicado: (2022)

Benchmarking of Decision-Support Tools Used for Tiered Sustainable Remediation Appraisal
por: Smith, Jonathan W. N., et al.
Publicado: (2013)

Formulary Management in the Department of Defense
por: Trice, Shana, et al.
Publicado: (2009)

The veterinary formulary /
Publicado: (2001)

The chemical formulary
Publicado: (1933)

The National Formulary
Publicado: (1955)

The Pocket Formulary
Publicado: (1852)

Dental Formulary
Publicado: (1911)

Formulary: Gonorrhœa
por: Roy, Don
Publicado: (1880)

Griffith’s Formulary
Publicado: (1874)

Reese’s Formulary
Publicado: (1850)

Association of Formulary Exclusions and Restrictions for Opioid Alternatives With Opioid Prescribing Among Medicare Beneficiaries
por: Rao, Tanvi, et al.
Publicado: (2020)

Does Variation among Provincial Drug Formulary Antimicrobial Listings in Canada Influence Prescribing Rates?
por: Glass-Kaastra, Shiona K., et al.
Publicado: (2014)

The Effect of Copayments for Prescriptions on Adherence to Prescription Medicines in Publicly Insured Populations; A Systematic Review and Meta-Analysis
por: Sinnott, Sarah-Jo, et al.
Publicado: (2013)

Cost sharing for breast cancer hormone therapy: How do dual eligible patients’ copayment impact adherence
por: Ma, Siyu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_aub9v3soh2gc5b2c7i83ejmhhr